​

Actuate Therapeutics Ownership | Who Owns Actuate Therapeutics?

OverviewFinancialsChart

Actuate Therapeutics Ownership Summary

Actuate Therapeutics is owned by 57.53% institutional investors, 17.84% insiders, and 24.64% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 51.11% of ACTU shares.

ACTU Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockActuate Therapeutics57.53%17.84%24.64%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bios capital management, lp9.97M51.11%$60.89M
Voss capital286.14K1.47%$1.75M
Blackrock funding, inc. /de195.45K1.00%$1.19M
Northwestern university27.78K0.14%$169.72K
Gleason group19.03K0.10%$116.26K
Chicago partners investment group10.37K0.05%$68.41K
Freestone capital10.00K0.05%$61.10K
Tang capital management5.24K0.03%$32.03K
Sterling capital management14.000.00%$86.00
Kg&l capital management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bios capital management, lp9.97M83.89%$60.89M
Northwestern university27.78K0.30%$169.72K
Voss capital286.14K0.12%$1.75M
Gleason group19.03K0.01%$116.26K
Freestone capital10.00K0.00%$61.10K
Chicago partners investment group10.37K0.00%$68.41K
Tang capital management5.24K0.00%$32.03K
Blackrock funding, inc. /de195.45K-$1.19M
Mercer global advisors inc /adv---
Sigma planning---

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de195.45K-187.85K
Voss capital286.14K0.12%143.76K
Bios capital management, lp9.97M83.89%71.43K
Gleason group19.03K0.01%19.03K
Tang capital management5.24K0.00%5.24K

Top Sellers

HolderShares% AssetsChange
Sigma planning---23.68K
Mercer global advisors inc /adv---16.34K
Marshall wace, llp---16.11K
Kg&l capital management---12.00K
Northwestern university27.78K0.30%-

New Positions

HolderShares% AssetsChangeValue
Gleason group19.03K0.01%19.03K$116.26K
Tang capital management5.24K0.00%5.24K$32.03K
Sterling capital management14.00-14.00$86.00

Sold Out

HolderChange
Kg&l capital management-12.00K
Marshall wace, llp-16.11K
Mercer global advisors inc /adv-16.34K
Sigma planning-23.68K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20253748.00%11,216,2307.83%572.02%3268.42%2100.00%
Mar 31, 20252531.58%10,401,5922.82%530.37%1935.71%1-50.00%
Dec 31, 20241990.00%10,116,1362547.05%120960.02%1440.00%2-
Sep 30, 202410-382,167-3-10---

Recent Insider Transactions

DateNameRoleActivityValue
Jun 27, 2025Bios Equity COF, LP Buy$500.00K
Jun 27, 2025Bios Equity COF, LP Buy$500.00K
Jun 27, 2025Kreis Leslie W. Buy$500.00K
Jun 27, 2025Kreis Leslie W. Buy$500.00K
Jun 27, 2025Fletcher Aaron G.L. Buy$500.00K

Insider Transactions Trends

DateBuySell
2025 Q2--
2014 Q2--
2013 Q2--
2012 Q4--
2012 Q2--

ACTU Ownership FAQ

Who Owns Actuate Therapeutics?

Actuate Therapeutics shareholders are primarily institutional investors at 57.53%, followed by 17.84% insiders and 24.63% retail investors. The average institutional ownership in Actuate Therapeutics's industry, Biotech Stocks , is 304.14%, which Actuate Therapeutics falls below.

Who owns the most shares of Actuate Therapeutics?

Actuate Therapeutics’s largest shareholders are Bios capital management, lp (9.97M shares, 51.11%), Voss capital (286.14K shares, 1.47%), and Blackrock funding, inc. /de (195.45K shares, 1.00%). Together, they hold 53.58% of Actuate Therapeutics’s total shares outstanding.

Does Blackrock own Actuate Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Actuate Therapeutics.

Who is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Actuate Therapeutics’s biggest shareholder by percentage of total assets invested, with 83.89% of its assets in 9.97M Actuate Therapeutics shares, valued at 60.89M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools